Markers for efficacy of mammalian target of rapamycin inhibitor

Yu Min Liao, Alex Sy, Yun Yen

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Mammalian target of rapamycin (mTOR), an important sensor for growth factors, nutritional deprivation and other stresses in controling translation, plays a critical role in tumorigenesis. Several rapalogs exhibited antitumor activity clinically, with a modest average response rate, while a small subset of patients exhibited significantly greater clinical benefits. A better understanding of cellular mechanisms and the results of clinical studies can help identify an optimal biomarker to predict the efficacy of mTOR inhibitors. We discuss these potential markers in terms of selection of candidates, baseline expression, pathway inhibition and source of targeted protein.

Original languageEnglish
Pages (from-to)4235-4244
Number of pages10
JournalAnticancer Research
Volume32
Issue number10
Publication statusPublished - Oct 2012

Fingerprint

Sirolimus
Intercellular Signaling Peptides and Proteins
Carcinogenesis
Biomarkers
Proteins
Clinical Studies

Keywords

  • Biomarker
  • mTOR inhibitor
  • Rapamycin
  • Review

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Markers for efficacy of mammalian target of rapamycin inhibitor. / Liao, Yu Min; Sy, Alex; Yen, Yun.

In: Anticancer Research, Vol. 32, No. 10, 10.2012, p. 4235-4244.

Research output: Contribution to journalArticle

Liao, Yu Min ; Sy, Alex ; Yen, Yun. / Markers for efficacy of mammalian target of rapamycin inhibitor. In: Anticancer Research. 2012 ; Vol. 32, No. 10. pp. 4235-4244.
@article{3b9e116e2e0b443296e0ccc676ca7878,
title = "Markers for efficacy of mammalian target of rapamycin inhibitor",
abstract = "Mammalian target of rapamycin (mTOR), an important sensor for growth factors, nutritional deprivation and other stresses in controling translation, plays a critical role in tumorigenesis. Several rapalogs exhibited antitumor activity clinically, with a modest average response rate, while a small subset of patients exhibited significantly greater clinical benefits. A better understanding of cellular mechanisms and the results of clinical studies can help identify an optimal biomarker to predict the efficacy of mTOR inhibitors. We discuss these potential markers in terms of selection of candidates, baseline expression, pathway inhibition and source of targeted protein.",
keywords = "Biomarker, mTOR inhibitor, Rapamycin, Review",
author = "Liao, {Yu Min} and Alex Sy and Yun Yen",
year = "2012",
month = "10",
language = "English",
volume = "32",
pages = "4235--4244",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "10",

}

TY - JOUR

T1 - Markers for efficacy of mammalian target of rapamycin inhibitor

AU - Liao, Yu Min

AU - Sy, Alex

AU - Yen, Yun

PY - 2012/10

Y1 - 2012/10

N2 - Mammalian target of rapamycin (mTOR), an important sensor for growth factors, nutritional deprivation and other stresses in controling translation, plays a critical role in tumorigenesis. Several rapalogs exhibited antitumor activity clinically, with a modest average response rate, while a small subset of patients exhibited significantly greater clinical benefits. A better understanding of cellular mechanisms and the results of clinical studies can help identify an optimal biomarker to predict the efficacy of mTOR inhibitors. We discuss these potential markers in terms of selection of candidates, baseline expression, pathway inhibition and source of targeted protein.

AB - Mammalian target of rapamycin (mTOR), an important sensor for growth factors, nutritional deprivation and other stresses in controling translation, plays a critical role in tumorigenesis. Several rapalogs exhibited antitumor activity clinically, with a modest average response rate, while a small subset of patients exhibited significantly greater clinical benefits. A better understanding of cellular mechanisms and the results of clinical studies can help identify an optimal biomarker to predict the efficacy of mTOR inhibitors. We discuss these potential markers in terms of selection of candidates, baseline expression, pathway inhibition and source of targeted protein.

KW - Biomarker

KW - mTOR inhibitor

KW - Rapamycin

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=84867773481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867773481&partnerID=8YFLogxK

M3 - Article

C2 - 23060543

AN - SCOPUS:84867773481

VL - 32

SP - 4235

EP - 4244

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 10

ER -